(19)
(11) EP 2 267 452 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
14.11.2012 Bulletin 2012/46

(45) Mention of the grant of the patent:
25.07.2012 Bulletin 2012/30

(21) Application number: 10173342.6

(22) Date of filing: 24.06.2002
(27) Previously filed application:
 24.06.2002 PCT/EP02/06956
(51) International Patent Classification (IPC): 
G01N 33/543(2006.01)
 G01N 33/569(2006.01)

(54)

A soluble complex comprising a retroviral surface glycoprotein

Löslicher Komplex mit einem retroviralen Oberflächenglykoprotein

Complexe soluble comportant une glycoprotéine de surface rétrovirale

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 22.06.2001 EP 01115225
31.08.2001 EP 01120939

(43) Date of publication of application:
29.12.2010 Bulletin 2010/52

(62) Application number of the earlier application in accordance with Art. 76 EPC:
02758265.9 / 1402015

(73) Proprietors:
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)
    Designated Contracting States:
    DE 
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)
    Designated Contracting States:
    AT BE CH CY DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR 

(72) Inventors:
  • Scholz, Christian
    82377 Penzberg (DE)
  • Andres, Herbert
    82377 Penzberg (DE)
  • Engel, Alfred
    82362 Weilheim (DE)
  • Faatz, Elke
    82386 Huglfing (DE)
  • Sizmann, Dorothea
    82393 Iffeldorf (DE)

(74) Representative: Burger, Alexander 
Roche Diagnostics GmbH Patent Department (TR-E) Nonnenwald 2
82377 Penzberg
82377 Penzberg (DE)


(56) References cited: : 
EP-A2- 0 280 211
DE-A1- 19 913 117
 EP-A2- 0 696 640
   
  • SCHOLZ C ET AL: "Functional Solubilization of Aggregation-prone HIV Envelope Proteins by Covalent Fusion with Chaperone Modules" JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1016/J.JMB.2004.10.091, vol. 345, no. 5, 4 February 2005 (2005-02-04), pages 1229-1241, XP004731715 ISSN: 0022-2836
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).